Mobix Labs Broadens Product Portfolio to Include Medical Technology Sector

Rhea-AI Summary

Mobix Labs, Inc. (Nasdaq: MOBX) confirms sales of proprietary electromagnetic filtering products to GE HealthCare and PerkinElmer for pharmaceutical diagnostics and digital imaging. The company's expansion into the medical technology sector showcases diversification and commitment to innovative solutions in healthcare.

Market Research Analyst

The announcement from Mobix Labs highlights their penetration into the medical technology sector, which can be seen as a strategic move diversifying their revenue streams. Given the robust nature of the healthcare industry, especially in the pharmaceutical diagnostics and digital imaging subsectors, this development could signal a strengthening of Mobix Labs' market position.

By securing end users like GE HealthCare and PerkinElmer, both of which are key players in the medical field, Mobix Labs is not only expanding its client base but also aligning itself with established and credible partners. This can enhance their brand reputation and potentially lead to more such collaborations.

From a market perspective, investors may view this positively as it suggests resilience against market volatility in other sectors. The consistent demand for healthcare technology, particularly for advanced diagnostics and imaging solutions, could provide a stable revenue source for Mobix Labs.

Financial Analyst

The financial implications of Mobix Labs' sales to GE HealthCare and PerkinElmer are multifaceted. On one hand, it represents an incremental revenue opportunity, which could improve the company's financial health. On the other hand, the costs associated with ramping up production to meet the demands of these large clients could impact short-term margins.

An important factor for investors to consider is the scalability of Mobix Labs' operations. With the adoption of their electromagnetic filtering products by such significant players, it's imperative to assess whether the company has the necessary infrastructure and supply chain capabilities to sustain and grow these relationships.

Long-term, the strategic focus on the medical sector may provide a hedge against cyclical downturns in other segments of their business, such as defense or aerospace, which are more sensitive to government spending and economic cycles.

Medical Technology Analyst

The technology being sold, proprietary electromagnetic filtering products, is critical for the performance of medical equipment like MRI and CT scanners. By improving the signal-to-noise ratio, these components are essential for producing high-quality images, which are important for accurate diagnoses.

The expertise required to develop such technology suggests that Mobix Labs has a strong R&D capability, which is a significant competitive advantage in the medical technology industry. This could lead to further innovations and patents, strengthening the company's intellectual property portfolio and potentially leading to higher valuations.

It's also worth noting the importance of regulatory compliance in the medical sector. Mobix Labs' ability to meet these stringent requirements can be seen as a testament to the quality and reliability of their products, which is paramount in healthcare applications.

--End Users include GE HealthCare and PerkinElmer

IRVINE, Calif.--(BUSINESS WIRE)--

Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs” or the “Company”), a fabless semiconductor company developing disruptive next-generation connectivity solutions for wired, wireless 5G, military, defense, aerospace, and medical industries, today confirmed it is selling proprietary electromagnetic filtering products to GE HealthCare and PerkinElmer for use in pharmaceutical diagnostics and digital imaging solutions.

“Mobix Labs’ ongoing product sales to GE HealthCare and PerkinElmer underscores the growing diversification of our product portfolio into the medical technology sector," stated Fabian Battaglia, CEO of Mobix Labs. "This expansion marks an exciting milestone as we further our commitment to advancing innovative solutions in the medical field. We are dedicated to supplying critical components for essential healthcare equipment such as MRI and CT scanners, contributing to the enhancement of our healthcare system.”

Mobix Labs began working with contract manufacturers who supply GE Healthcare in 2009, and PerkinElmer in 2017. All are utilizing Mobix Labs’ proprietary electromagnetic filtering solutions in their applications to improve the signal to noise levels of their products to improve their performance.

About Mobix Labs, Inc.

Based in Irvine, California, Mobix Labs is a fabless semiconductor company delivering mmWave 5G and C-Band wireless solutions and delivering connectivity and filtering products for next-generation communication systems supporting the aerospace, military, and high-reliability markets. The Company’s electromagnetic filtering products are used in military, aerospace, and medical applications. These technologies are designed for large and rapidly growing markets where there are increasing demands for higher-performance communication and filtering systems that utilize an expanding mix of both wireless and connectivity technologies. More information on the company can be found by visiting http://www.mobixlabs.com or by following us on X @MobixLabsInc and LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about capturing additional opportunities in the future, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement, such as Mobix Labs’ ability to deliver parts or to develop technology in connection with the systems provided to GE HealthCare and PerkinsElmer. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. All information provided in this press release is as of the date of this press release, and Mobix Labs undertakes no duty to update such information, except as required under applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240328971162/en/

Media Contact:

Jeff Fox, The Blueshirt Group

jeff@blueshirtgroup.com

Investor Contact:

Lori Barker, The Blueshirt Group

lori@blueshirtgroup.com

Source: Mobix Labs, Inc.

FAQ

What products is Mobix Labs selling to GE HealthCare and PerkinElmer?

Mobix Labs is selling proprietary electromagnetic filtering products to GE HealthCare and PerkinElmer for use in pharmaceutical diagnostics and digital imaging solutions.

When did Mobix Labs start working with contract manufacturers who supply GE Healthcare and PerkinElmer?

Mobix Labs began working with contract manufacturers who supply GE Healthcare in 2009 and PerkinElmer in 2017.

How is Mobix Labs contributing to the medical field?

Mobix Labs is supplying critical components for essential healthcare equipment such as MRI and CT scanners to improve the signal to noise levels of products and enhance performance in the medical field.